


Searching News Database: SCH 530348
HSMN NewsFeed - 24 Mar 2007
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
Additional items found! 1
Members Archive contains
1 additional stories matching:
SCH 530348
(Password required)
SCH 530348
(Password required)
